Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received ...
Investors are digesting better-than-expected inflation data and bracing for the next move in Trump's escalating trade war.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback